|
|
???tair.name??? >
???browser.page.title.author???
|
"yang j c h"???jsp.browse.items-by-author.description???
Showing items 391-415 of 428 (18 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page
| 國立成功大學 |
2018 |
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer
|
Wu, Y.-L.;Zhang, L.;Kim, D.-W.;Liu, X.;Lee, D.H.;Yang, J.C.-H.;Ahn, M.-J.;Vansteenkiste, J.F.;Su, W.-C.;Felip, E.;Chia, V.;Glaser, S.;Pultar, Pultar P.;Zhao, S.;Peng, B.;Akimov, M.;Tan, D.S.W. |
| 臺大學術典藏 |
2017 |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Yu C.-J.; Yang J.C.H.; Lin C.-C.; Lin Z.-Z.; Chen J.-S.; JIN-YUAN SHIH; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yao Z.-H.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Jin-Yuan Shih;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J. |
| 臺大學術典藏 |
2017 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer
|
Lin Y.-T.;Liu Y.-N.;Wu S.-G.;Yang J.C.-H.;Jin-Yuan Shih; Lin Y.-T.; Liu Y.-N.; Wu S.-G.; Yang J.C.-H.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2017 |
Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry
|
Gautschi O.;Milia J.;Filleron T.;Wolf J.;Carbone D.P.;Owen D.;Camidge R.;Narayanan V.;Doebele R.C.;Besse B.;Remon-Masip J.;Janne P.A.;Awad M.M.;Peled N.;Byoung C.-C.;Karp D.D.;Van Den Heuvel M.;Wakelee H.A.;Neal J.W.;Mok T.S.K.;Yang J.C.H.;Ou S.-H.I.;Pall G.;Froesch P.;Zalcman G.;Gandara D.R.;Riess J.W.;Velcheti V.;Zeidler K.;Diebold J.;Fr?H M.;Michels S.;Monnet I.;Popat S.;Rosell R.;Karachaliou N.;Rothschild S.I.;Jin-Yuan Shih;Warth A.;Muley T.;Cabillic F.;Mazi?Res J.;Drilon A.; Michels S.; Monnet I.; Popat S.; Rosell R.; Karachaliou N.; Rothschild S.I.; JIN-YUAN SHIH; Warth A.; Muley T.; Cabillic F.; Mazi?res J.; Drilon A.; Gautschi O.; Milia J.; Filleron T.; Wolf J.; Carbone D.P.; Owen D.; Camidge R.; Narayanan V.; Doebele R.C.; Besse B.; Remon-Masip J.; Janne P.A.; Awad M.M.; Peled N.; Byoung C.-C.; Karp D.D.; Van Den Heuvel M.; Wakelee H.A.; Neal J.W.; Mok T.S.K.; Yang J.C.H.; Ou S.-H.I.; Pall G.; Froesch P.; Zalcman G.; Gandara D.R.; Riess J.W.; Velcheti V.; Zeidler K.; Diebold J.; Fr?h M. |
| 臺大學術典藏 |
2017 |
Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component
|
J?nne P.A.;Ghiorghiu S;Cantarini M;Mann H;Chia-Chi Lin;Hirashima T;Gold K;Novello S;Yoh K;Haggstrom D;Blackhall F;Felip E;Planchard D;Kim J.-H;Kim S.-W;Su W.-C;Sequist L.V;Ramalingam S.S;Kim D.-W;Ahn M.-J;Yang J.C.-H; Yang J.C.-H; Ahn M.-J; Kim D.-W; Ramalingam S.S; Sequist L.V; Su W.-C; Kim S.-W; Kim J.-H; Planchard D; Felip E; Blackhall F; Haggstrom D; Yoh K; Novello S; Gold K; Hirashima T; Chia-Chi Lin; Mann H; Cantarini M; Ghiorghiu S; J?nne P.A. |
| 國立成功大學 |
2017 |
Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial
|
Thress, K.S.;Jacobs, V.;Angell, H.K.;Yang, J.C.-H.;Sequist, L.V.;Blackhall, F.;Su, W.-C.;Schuler, M.;Wolf, J.;Gold, K.A.;Cantarini, M.;Barrett, J.C.;J�nne, P.A. |
| 國立成功大學 |
2017 |
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study
|
Ahn, M.-J.;Kim, D.-W.;Cho, B.C.;Kim, S.-W.;Lee, J.S.;Ahn, J.-S.;Kim, T.M.;Lin, C.-C.;Kim, H.R.;John, T.;Kao, S.;Goldman, J.W.;Su, W.-C.;Natale, R.;Rabbie, S.;Harrop, B.;Overend, P.;Yang, Z.;Yang, J.C.-H. |
| 國立成功大學 |
2017 |
Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors
|
Chang, I.-S.;Jiang, S.S.;Yang, J.C.-H.;Su, W.-C.;Chien, L.-H.;Hsiao, C.-F.;Lee, J.-H.;Chen, Chen C.-Y.;Chen, Chen C.-H.;Chang, G.-C.;Wang, Z.;Lo, F.-Y.;Chen, K.-Y.;Wang, Wang W.-C.;Chen, Y.-M.;Huang, M.-S.;Tsai, Y.-H.;Su, Y.-C.;Hsieh, W.-S.;Shih, W.-C.;Shieh, Shieh S.-H.;Yang, T.-Y.;Lan, Q.;Rothman, N.;Chen, Chen C.-J.;Chanock, S.J.;Yang, P.-C.;Hsiung, C.A. |
| 國立成功大學 |
2016-12 |
Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors or lymphoma
|
Lin, C. C.; Su, W. C.; Chao, Y.; Lee, J. H.; Hsu, C. H.; Cheng, A. L.; Chung, W. P.; Chen, M. H.; Lin, C. L.; Ho, H. L.; Huang, L. P.; Huang, C. T.; Hsueh, S. P.; Yang, J. C. H. |
| 國立臺灣大學 |
2016 |
Time to response in patients with ALK plus NSCLC receiving alectinib in the phase II NP28673 and NP28761 studies
|
Gandhi, L.; Gadgeel, S.; Shaw, A.; Barlesi, F.; Crino, L.; Yang, J. C-H.; Dingemans, A-M. C.; Kim, D-W.; de Marinis, F.; Schulz, M.; Liu, S.; Fish, S.; Kotb, A.; Ou, S-H. I.; 楊志新 |
| 國立臺灣大學 |
2016 |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
|
Schuler, M.; Yang, J. C. -H.; Park, K.; Kim, J. -H.; Bennouna, J.; Chen, Y. -M.; Chouaid, C.; De Marinis, F.; Feng, J. -F.; Grossi, F.; Kim, D. -W.; Liu, X.; Lu, S.; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C.; Wang, B.; Chand, V. K.; Planchard, D.; 楊志新 |
| 臺大學術典藏 |
2016 |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
|
Schuler, M.;Yang, J. C. -H.;Park, K.;Kim, J. -H.;Bennouna, J.;Chen, Y. -M.;Chouaid, C.;De Marinis, F.;Feng, J. -F.;Grossi, F.;Kim, D. -W.;Liu, X.;Lu, S.;Strausz, J.;Vinnyk, Y.;Wiewrodt, R.;Zhou, C.;Wang, B.;Chand, V. K.;Planchard, D.; 楊志新; Schuler, M.; Yang, J. C. -H.; Park, K.; Kim, J. -H.; Bennouna, J.; Chen, Y. -M.; Chouaid, C.; De Marinis, F.; Feng, J. -F.; Grossi, F.; Kim, D. -W.; Liu, X.; Lu, S.; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C.; Wang, B.; Chand, V. K.; Planchard, D. |
| 臺大學術典藏 |
2016 |
Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations
|
Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2016 |
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
|
Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; CHIA-HSIEN CHENG; Hsu F.-M.; Lu S.-L.; Lu S.-L.;Hsu F.-M.;Chen K.-Y.;Ho C.-C.;Yang J.C.-H.;Chia-Hsien Cheng |
| 臺大學術典藏 |
2016 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; JIN-YUAN SHIH; Chang Y.-L.; Tsai M.-F.; Wu S-G.;Liu Y.-N.;Tsai M.-F.;Chang Y.-L.;Yu C.-J.;Yang P.-C.;Yang J.C.-H.;Wen Y.-F.;Jin-Yuan Shih; Wu S-G.; Liu Y.-N. |
| 臺大學術典藏 |
2016 |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review
|
Lin Y.-T.; Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin Y.-T.;Yu C.-J.;Yang J.C.-H.;Jin-Yuan Shih |
| 臺大學術典藏 |
2016 |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; KAI-LUN YU; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 國立臺灣大學 |
2015 |
Efficacy by blind independent central review (BICR): Post hoc analyses of the phase III, multicentre, randomised IPASS study of 1st-line gefitinib (G) vs carboplatin/paclitaxel (C/P) in Asian patients (pts) with EGFR mutation-positive advanced NSCLC
|
Mok, T.; Saijo, N.; Thongprasert, S.; Yang, J. C. -H.; Wu, Y. -L.; Young, H.; Haddad, V.; Jiang, H.; Fukuoka, M.; 楊志新 |
| 國立臺灣大學 |
2015 |
Afatinib (A) versus chemotherapy (CT) for EGFR mutation-positive NSCLC patients (pts) aged >= 65 years: Subgroup analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)
|
Wu, Y. -L.; Sequist, L. V.; Geater, S. L.; Orlov, S.; Lee, K. H.; Tsai, C. -M.; Kato, T.; Kiura, K.; Barrios, C. H.; Schuler, M.; Hirsh, V.; Yamamoto, N.; O'Byrne, K.; Mok, T.; Massey, D.; Maerten, A.; Yang, J. C. -H.; 楊志新 |
| 國立臺灣大學 |
2015 |
EGFR Mutation Status Is Associated With Better Radiographic Response and Predicts Favorable Outcomes in Non-Small Cell Lung Cancer Patients With Brain Metastases Treated by Stereotactic Radiosurgery
|
Yang, W. C.; Xiao, F. R.; Shih, J. Y.; Ho, C. C.; Chen, Y. F.; Tseng, H. M.; Chen, K. Y.; Liao, W. Y.; Yu, C. J.; Yang, J. C. H.; Kuo, S. H.; Cheng, J. C. H.; Yang, P. C.; Hsu, F. M.; 曾漢民; 陳雅芳; 楊泮池; 廖唯昱; 郭頌鑫; 陳冠宇; 余忠仁; 成佳憲; 何肇基; 蕭輔仁; 施金元; 許?銘 |
| 臺大學術典藏 |
2015 |
The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
|
Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Shao Y.-Y.;Hsu C.;Wen-Fang Cheng;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S. |
| 臺大學術典藏 |
2015 |
Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy
|
Yang J.C.H.; Shih J.Y; Chia-Chi Lin; Liao B.C |
| 臺大學術典藏 |
2015 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai T.-H.; Wu S.-G.; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2015 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
YA-FANG CHEN; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.; Lin C.-C.; Lee J.-H.; Liao B.-C. |
| 臺大學術典藏 |
2015 |
Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis
|
CHIA-LIN HSU; Chen J.-H.; Chen K.-Y.; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Yang P.-C. |
Showing items 391-415 of 428 (18 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page
|
